Home » Topics » BioWorld Science

BioWorld Science
RSS

Poor sleep quality in people with HIV is linked to lower CSF Abeta42 levels

July 21, 2021

German clearance for phase I/IIa study of HDP-101 in multiple myeloma

July 21, 2021

Affinia and IOB collaborate to design novel CNS promoters for gene therapy

July 21, 2021

CA-125 is a diagnostic marker of tuberculosis in patients without HIV

July 21, 2021

Lantern reports promising new preclinical data for LP-184 in pancreatic cancer

July 21, 2021

Updated interim data from ongoing phase I/IIa study of OpRegen in dry AMD with GA

July 21, 2021

NIMIUM and Paraza partner to develop G3PP activators to treat cardiometabolic diseases

July 21, 2021

First participants dosed in phase Ib/IIa FOCUSC9 study of WVE-004

July 21, 2021

Latvian Institute of Organic Synthesis discloses tubulin polymerization inhibitors

July 21, 2021

Wigen Biomedicine Technology presents GTPase KRAS mutant inhibitors

July 21, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...